<DOC>
	<DOCNO>NCT01578850</DOCNO>
	<brief_summary>To compare maintenance efficacy combination etanercept 50 mg weekly plus methotrexate without disease modify antirheumatic drug therapy methotrexate without disease modify antirheumatic drug therapy Week 52 subject moderately severely active rheumatoid arthritis achieve low disease activity 24 week therapy open label etanercept 50 mg weekly plus MTX without disease modify antirheumatic drug therapy .</brief_summary>
	<brief_title>Study Conducted Subjects With Rheumatoid Arthritis Who Have Moderate Severe Disease Activity Despite Methotrexate Therapy With Without Other Non Biologic Disease Modifying Antirheumatic Drugs ( DMARDs ) Least 12 Weeks Prior Screening</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Etanercept</mesh_term>
	<mesh_term>Antirheumatic Agents</mesh_term>
	<criteria>1 . Subject minimum 1 year history/diagnosis rheumatoid arthritis base 1987 American College Rheumatology ( ACR ) Revised criterion RA . 2 . Subject must active rheumatoid arthritis despite methotrexate ( MTX ) therapy â‰¥10 mg/wk least 12 week . The MTX dose must stable least 4 week immediately prior screening . 1 . Subjects use follow systemic treatment washout period give : 1 . Oral corticosteroid dose prednisone &gt; 7.5 mg/day ( equivalent ) change dose within 28 day baseline . 2 . Treatment 1 NSAID within 14 day baseline . 3 . Methotrexate dose great 25 mg/week , change dose methotrexate within 28 day baseline . 4 . Subjects allow continue follow non biologic DMARDs : sulfasalazine , hydroxychloroquine , leflumomide . All nonbiologic DMARDs ( include limit gold , penicillamine , azathioprine , cyclophospamide ) , biologic DMARDs must discontinue least 2 month prior Week 1 . 5 . Any biologic B cell deplete agent ( eg , rituximab ) within 2 year Week 1 . 2 . Receipt live ( attenuate ) vaccine within 4 week prior baseline . 3 . Receipt live ( attenuate ) vaccine within 4 week prior baseline .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>rheumatoid arthritis</keyword>
	<keyword>etanercept</keyword>
	<keyword>methotrexate</keyword>
	<keyword>DMARDs</keyword>
</DOC>